India Anti-Obesity Drugs Market Press Release Template
As indicated in the latest market research report published by IMARC Group, titled "India Anti-Obesity Drugs Market Report by Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs), Drug Type (Prescription Drugs, OTC Drugs), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market.
Market Size & Future Growth Potential:
The India anti-obesity drugs market size reached USD 80.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 190.0 Million by 2033, exhibiting a growth rate (CAGR) of 9.9% during 2025-2033.
Note: “We are currently updating our reports to the 2026–2034 period. If you need the latest data, information, and industry insights, please click on “Request Free Sample Report”
Recent News and Developments:
- Eli Lilly's Market Entry (July 2024): Eli Lilly obtained approvals for importing and distributing tirzepatide-based weight-loss medications Zepbound and Mounjaro in India, marking a significant milestone in the country's anti-obesity drug landscape.
- Biosimilar Launch by Glenmark (2024): Glenmark Pharmaceuticals launched Lirafit, a biosimilar version of liraglutide, making GLP-1 receptor agonist therapy more accessible and affordable for Indian patients.
- Government Production Incentives: India announced plans to offer production-linked incentives (PLI) for local manufacturing of GLP-1 drugs targeting diabetes and obesity by 2026, aiming to reduce import dependency and increase affordability.
- Novo Nordisk's Semaglutide Launch: The company launched semaglutide for obesity treatment in India, expanding treatment options for patients who have struggled with traditional weight management approaches.
- Market Inflection Point Recognition: Industry experts have identified 2024 as a pivotal year for obesity medication markets globally, with increasing recognition of obesity as a treatable medical condition requiring pharmaceutical intervention.
- Digital Health Integration: Online pharmacy platforms and telemedicine services are increasingly incorporating anti-obesity medications into their offerings, improving accessibility for patients across different geographical regions.
Request Free Sample Report: https://www.imarcgroup.com/india-anti-obesity-drugs-market/requestsample
India Anti-Obesity Drugs Market Trends:
The India Anti-Obesity Drugs Market is experiencing rapid evolution as rising lifestyle diseases and growing health awareness push consumers toward evidence-based medical weight-management solutions. With obesity becoming increasingly common across urban and semi-urban regions, more patients are seeking clinically approved drugs instead of relying solely on fad diets or quick-fix remedies. Moreover, the shift toward prescription-based weight-loss therapies—supported by endocrinologists, diabetologists, and bariatric specialists—is expanding the market for safe and regulated anti-obesity formulations. Additionally, modern drugs that help manage appetite, improve metabolism, or regulate fat absorption are gaining traction, especially among individuals managing comorbidities like diabetes, hypertension, and PCOS.
In addition, digital health platforms and teleconsultation services are making access to qualified medical advice easier, enabling early diagnosis and structured obesity management. Consumer interest in combination therapies, personalized treatment plans, and long-term weight-management programs is also on the rise. Furthermore, the influence of fitness apps, wellness influencers, and preventive healthcare campaigns is encouraging patients to integrate medically supervised medication with lifestyle modifications. Together, these trends highlight a market shifting toward science-backed, doctor-prescribed, and patient-centric obesity management solutions in India.
Market Scope and Growth Factors:
The India Anti-Obesity Drugs Market continues to expand strongly due to rising obesity prevalence, sedentary lifestyles, and increasing awareness of obesity-related complications. The growing incidence of metabolic disorders—such as type 2 diabetes, cardiovascular conditions, and hormonal imbalances—is driving higher demand for anti-obesity medications recommended as part of comprehensive treatment plans. Moreover, improved access to healthcare facilities, growing insurance coverage, and the expansion of private clinics specializing in weight management are enabling more patients to seek medical treatment. Additionally, rising incomes and changing dietary habits are prompting individuals to take proactive measures to maintain healthier body weight, increasing demand for clinically tested drugs with proven safety profiles.
In addition, pharmaceutical companies are investing in research, patient-support programs, and formulation upgrades to develop more effective obesity therapies tailored to Indian patient needs. The growth of e-pharmacies and online consultation platforms is also making prescription fulfilment more convenient, especially in smaller cities. Furthermore, government-backed awareness initiatives promoting preventive healthcare are encouraging early intervention and structured management of obesity across age groups. Together, these growth drivers keep the India Anti-Obesity Drugs Market on a strong upward trajectory—supported by rising health consciousness, improved medical access, and expanding clinical adoption of safe, regulated obesity treatments.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/india-anti-obesity-drugs-market
Comprehensive Market Report Highlights & Segmentation Analysis:
The market report offers a comprehensive analysis of the segments, highlighting those with the largest India Anti-Obesity Drugs Market Share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments.
Segmentation by Drug Class:
- Peripherally Acting Drugs
- Centrally Acting Drugs
Segmentation by Drug Type:
- Prescription Drugs
- OTC Drugs
Segmentation by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Segmentation by Regional:
- North India
- South India
- East India
- West India
Competitor Landscape:
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.
Key highlights of the Report:
- Historical Market Performance
- Future Market Projections
- Impact of COVID-19 on Market Dynamics
- Industry Competitive Analysis (Porter's Five Forces)
- Market Dynamics and Growth Drivers
- SWOT Analysis (Strengths, Weaknesses, Opportunities, Threats)
- Market Ecosystem and Value Creation Framework
- Competitive Positioning and Benchmarking Strategies
Major Advantages of the Report:
- This report provides market leaders and new entrants with accurate revenue estimates for the overall market and its key subsegments.
- Stakeholders can leverage this report to gain a deeper understanding of the competitive landscape, enabling them to strategically position their businesses and develop effective go-to-market strategies.
- The report provides stakeholders with valuable insights into the market dynamics, offering a comprehensive analysis of key drivers, restraints, challenges, and opportunities.
Why Choose IMARC Group:
- Extensive Industry Expertise
- Robust Research Methodology
- Insightful Data-Driven Analysis
- Precise Forecasting Capabilities
- Established Track Record of Success
- Reach with an Extensive Network
- Tailored Solutions to Meet Client Needs
- Commitment to Strong Client Relationships and Focus
- Timely Project Delivery
- Cost-Effective Service Options
Note: Should you require specific information not included in the current report, we are pleased to offer customization options to meet your needs.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: +1-201971-6302 | Africa and Europe: +44-702-409-7331
Comments